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Summary
Autistic disorder is a complex genetic disease. Because
of previous reports of individuals with autistic disorder
with duplications of the Prader-Willi/Angelman syn-
drome critical region, we screened severalmarkers across
the 15q11-13 region, for linkage disequilibrium. One
hundred forty families, consisting predominantly of a
child with autistic disorder and both parents, were stud-
ied. Genotyping was performed by use of multiplex PCR
and capillary electrophoresis. Two children were iden-
tified who had interstitial chromosome 15 duplications
and were excluded from further linkage-disequilibrium
analysis. Use of the multiallelic transmission-disequilib-
rium test (MTDT), for nine loci on 15q11-13, revealed
linkage disequilibrium between autistic disorder and a
marker in the g-aminobutyric acidA receptor subunit
gene, GABRB3 155CA-2 (MTDT 28.63, 10 df, P 
). No evidence was found for parent-of-origin ef-.0014
fects on allelic transmission. The convergence of
GABRB3 as a positional and functional candidate along
with the linkage-disequilibrium data suggests the need
for further investigation of the role of GABRB3 or ad-
jacent genes in autistic disorder.
Introduction
Autistic disorder is a complex genetic disease with evi-
dence of high MZ twin concordance, relative to DZ twin
concordance (Folstein and Rutter 1977; Ritvo et al.
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1985; Steffenburg et al. 1989; Bailey et al. 1995), and
a high relative sibling recurrence risk (reviewed in Smal-
ley 1997). Several genomewide screens are in progress.
Although several candidate-gene associations have been
reported (Comings et al. 1991; He´rault et al. 1993; War-
ren et al. 1996), only one has reported the results of a
family-based control design (Cook et al. 1997a). In this
latter study, a haplotype consisting of the short form of
a promoter variant and an intron 2 polymorphism in
the serotonin transporter gene ( ) wasHTT  SLC 6A4
preferentially transmitted in a U.S. sample. However, this
finding would not be significant if type I error was Bon-
ferroni corrected for all loci tested. In addition, a dif-
ferent haplotype at HTT recently was found to be pref-
erentially transmitted in a sample of German subjects
with autistic disorder (Klauck et al. 1997). It is antici-
pated that several loci will contribute to autistic disorder
susceptibility (Pickles et al. 1995).
Historically, cytogenetic abnormalities have some-
times provided information helpful in the localization of
disease-susceptibility loci. In recent years, duplication of
the Prader-Willi/Angelman syndrome critical region
(15q11-13) has been described in several individuals
with autistic disorder (Gillberg et al. 1991; Robinson et
al. 1993; Baker et al. 1994; Bundey et al. 1994; Leana-
Cox et al. 1994; Schinzel et al. 1994; Crolla et al. 1995;
Hotof and Bolton 1995; Flejter et al. 1996; Cook et al.
1997b). Because patients seen in our clinic who had
15q11-13 duplications had classic symptoms of autistic
disorder, we initiated linkage-disequilibrium studies of
this region, in early 1996.
To determine whether the patients with 15q11-13 du-
plications indicated an autistic disorder–susceptibility
locus in the region, linkage-disequilibrium studies of
15q11-13 loci between D15S128 and D15S156 were
conducted. Previously reported duplications of 15q11-
13 in autistic disorder have been exclusively of maternal
origin, and two reports have suggested that duplications
of maternal, but not paternal, origin increase the risk
for developmental disorders (Browne et al. 1997; Cook
et al. 1997b). UBE3A is expressed exclusively from the
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Table 1






Heterozygosity MTDT x2 df P Value
D15S128 300a,b .80 6.72 8 .5667
D15S1506 100b .70 4.52 8 .8074
UBE3A Intron 1 50b .21 .16 1 .6892
D15S122 20b .75 12.10 8 .1466
D15S10 .2 .51 3.31 3 .3458
UBE3A OP2 3A/3B 1,000b .32 .05 1 .8231
D15S97 150c .83 8.59 9 .4763
GABRB3 155CA-2 800c,d .79 28.63 10 .0014
D15S156 .54 3.23 4 .5193
NOTE.—The relationship between genetic and physical distance varies in this region, but this area of ∼2.4
Mb has a sex-averaged genetic distance of ∼8.1 cM (Robinson and Lalande 1995). Distances are physical
estimates based on available physical or genetic mapping data.
a From Christian et al. (in press).
b From Sutcliffe et al. (1997).
c From Glatt et al. (1997).
d From Robinson and Lalande (1995).
Table 2
Transmission Data for Each Allele of GABRB3 155CA-2
ALLELE n PERCENTAGE
PATERNAL MATERNAL COMBINED
TR NT x2 TR NT x2 TR NT x2
85 1 .2 0 0 0 1 0 1 1 0 1
87 167 32 19 32 3.31 22 30 1.23 44 65 4.05
89 53 10.2 11 16 .93 7 15 2.91 18 31 3.45
91 1 .2 0 0 0 0 1 1 0 1 1
93 1 .2 0 1 1 0 0 0 0 1 1
95 16 3.1 2 5 1.29 5 4 .11 7 9 .25
97 11 2.1 3 2 .2 6 0 6 9 2 4.45
99 84 16.1 15 12 .33 18 17 .03 34 30 .25
101 68 13 10 11 .05 11 16 .93 21 27 .75
103 87 16.7 29 11 8.1 19 8 4.48 50 21 11.85
105 12 2.3 3 3 0 3 3 0 6 6 0
107 4 .8 0 3 3 1 0 1 1 3 1
109 9 1.7 3 0 3 3 3 0 6 3 1
111 6 1.1 2 0 2 3 1 1 5 1 2.67
113 2 .4 0 1 1 0 1 1 0 2 2
NOTE.—TR  transmitted; NT  not transmitted. The genotype of CEPH individual 884-15
was 99/103. Only transmissions from heterozygous parents were included. For parent-child pairs,
only transmissions from a heterozygous parent to a heterozygous child with a different genotype
were included.
maternal chromosome (Albrecht et al. 1997), at some
neuroanatomical sites reported to be abnormal in au-
tistic disorder (e.g., the hippocampus and cerebellar Pur-
kinje cells) (reviewed in Courchesne 1997). Therefore,
several UBE3A markers were included. Results are re-
ported for the first 138 consecutive families meeting in-
clusion criteria of a planned sample of 350 families.
Subjects and Methods
Subjects
Consecutive subjects consenting to participate in a
family-based linkage-disequilibrium study of candidate
loci for autistic disorder were studied between June 1994
and October 1997 at the University of Chicago Devel-
opmental Disorders Clinic and between July 1990 and
October 1997 at the Laboratory for Research on the
Neuroscience of Autism, Children’s Hospital Research
Center, La Jolla. The study was approved by both in-
stitutional review boards. Inclusion criteria included the
following: (1) diagnosis of autistic disorder, by use of
the Autism Diagnostic Interview–Revised (ADI-R) (Lord
et al. 1994) and age-appropriate versions of the Autism
Diagnostic Observation Schedule (Lord et al. 1989) or
the Pre-Linguistic Autism Diagnostic Observation
Schedule (DiLavore et al. 1995); (2) mental age 118 mo,
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as assessed by the Vineland Adaptive Behavior Scales
(Sparrow et al. 1984); (3) nonverbal IQ 135; (4) con-
firmation of the diagnosis of autistic disorder, by a child
psychologist (C.L.) and a child psychiatrist (E.H.C. or
B.L.L.) or by a child psychologist (A.L.) and a child
neurologist (R.H.); and (5) exclusion of known etiolo-
gies of autistic disorder, by physical examination, in-
cluding neurological examination and Wood’s lamp ex-
amination to exclude tuberous sclerosis (Smalley et al.
1992). FRAXA DNA testing was performed and was
found to be negative for 136 of the 140 probands. Ow-
ing to insufficient DNA and the absence of clinical sus-
picion of fragile X syndrome, FRAXA DNA testing was
not performed in four of the subjects. For three of these
four subjects, FRAXA DNA testing was negative for an
affected sibling but was not performed for the proband.
In the process of genotyping, two individuals with au-
tistic disorder, of the 140 consecutive cases meeting cri-
teria for inclusion in this study, were identified to have
interstitial 15q11-13 duplications. The first case has
been reported elsewhere (Cook et al. 1997b), because
the affected sibling shared the interstitial duplication of
maternal origin and because the unaffected mother had
a duplication of paternal origin. The second case has a
de novo interstitial duplication of maternal origin.
The sample of families meeting full inclusion criteria
includes six affected-sibling pairs in which each child
meeting the criteria was considered as a separate pro-
band, for generation of parent-child trios (no parent-
child pairs in the families with two affected children).
There were 13 parent-child pairs and 125 trios, con-
sisting of a child and both parents.
Of the probands, 119 were male and 19 were female.
One hundred fourteen were Caucasian, 6 were African
American, 13 were Asian American, and 5 were His-
panic. The mean age was years. The mean7.6 6.2
nonverbal mental age was years, and the mean6.0 5.8
nonverbal IQ was . The mean ADI-R scores79.2 25.3
were as follows: social, ; communication,21.7 4.7
; and restricted and repetitive behaviors,14.6 3.9
.6.3 2.2
For the first 86 families of this sample, preliminary
findings for the HTT gene have been published previ-
ously (Cook et al. 1997a). For the larger sample, ge-
notyping at HTT is ongoing. Other genes that have been
screened, in part of this sample, by use of the transmis-
sion-disequilibrium test (TDT), include HTR1A,
HTR2A, HTR2C, HTR6, HTR7, TPH, PRKCQ,
HRAS, DRD2, and TNFA, a gene in the major histo-
compatibility complex region.
Genotyping
Blood was collected, by venipuncture, into lavender
top Vacutainer tubes. Blood was extracted by use of the
PureGene DNA Isolation Kit (Gentra Systems). Geno-
typing was performed blind to the inclusion status of
the probands and to family information.
Multiplex PCR reactions were optimized by starting
with equal concentrations of all primers and then were
adjusted to yield peak heights of one-third the maximum
fluorescence-detection limit. PCR amplification for the
first set of four microsatellite markers was carried out
in a final volume of 10 ml consisting of 50 ng genomic
DNA, 10 mM Tris HCl, 50 mM KCl, 200 mM dNTPs,
2.5 mM MgCl2, 0.3 units TaqGold polymerase, 0.001%
gelatin, and sense and antisense primers of the following
concentrations: 100 nM sense and 313 nM antisense
D15S128, 1.25 mM D15S122, 232 nM D15S97, and 48
nM D15S156. The initial activation step for heat-acti-
vated DNA polymerase was carried out at 95C for 12
min, followed by 10 cycles of 95C for 15 s, 55C for
30 s, and 72C for 30 s and by 28 subsequent cycles in
which the denaturation temperature was reduced to
89C. Final extension was at 72C for 30 min.
D15S1506 and D15S10 were amplified under identical
multiplex conditions, except for the concentration of
primers (200 nM sense and 160 nM antisense D15S1506
and 500 nM D15S10), the annealing temperature
(55C), and the use of 30 cycles with a denaturation
temperature of 95C and no cycles at 89C denaturation.
A third PCR was run for GABRB3 155CA-2 (Glatt et
al. 1994). The final volume of 10 ml consisted of 50 ng
genomic DNA, 10 mM Tris HCl, 50 mM KCl, 0.001%
gelatin, 1.5 mM MgCl2, 0.6 units Taq polymerase, 200
mM dNTPs, 5% dimethyl sulfoxide, by volume, and a
concentration of sense and antisense primers of 500 nM
GABRB3 155CA-2. Initial activation for DNA poly-
merase was carried out at 94C for 2 min, followed by
29 cycles at 95C for 15 s, 61C for 30 s, and 72C for
60 s. Final extension was at 72C for 10 min. A 7-bp
insertion/deletion polymorphism was identified in which
there was a common deletion, at 805–811 bp, of the
OP2 genomic sequence (Entrez database [http://
www.ncbi.nlm.nih.gov] accession L23501) that overlaps
with the transcription-initiation site of at least one
UBE3A transcript (Kishino et al. 1997). Primers OP2
3A (5′-HEX-TGG TTA TAG TTG TGA GGC GGA
TAC-3′) (1 mM) and OP2 3B (5′-AAC TTG CAA CTT
TGT TGA TAA GCC-3′) (1 mM) were used in a PCR
with the same conditions as the first and second PCRs
described above, except that the annealing temperature
was 53.3C and the final extension was 2 min. A 3-bp
insertion/deletion polymorphism after the first coding
exon was amplified by use of 1 mM UBE3A e1A (5′-
HEX-CAC AGG TTA ATC ACT TCA GTG C-3′) and
1 mM UBE3A e1B (5′-TAA GCA CAG TGA TTA GTA
CA-3′). Conditions were the same as those used for the
first and second PCRs described above, except that the
annealing temperature was 58C.
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D15S10, D15S128, D15S122, D15S97, and D15S156
were obtained from Research Genetics, and GABRB3
155CA-2, D15S1506, OP2 3A, and UBE3A e1A were
synthesized by Applied Biosystems. Unlabeled primers
were synthesized at the Cancer Research Center at the
University of Chicago. All reactions were performed on
a GeneAmp PCR system 9600 thermocycler (Perkin-
Elmer).
PCR products were combined for injection, on the ABI
PRISM 310 Genetic Analyzer (Applied Biosystems), in
a final volume of 13.5 ml consisting of 12 ml deionized
formamide, 0.5 ml N,N,N′,N′-tetramethyl-6-carboxy-
rhodamine GS500 size standard, and 1.0 ml pooled PCR
products, consisting of pool 1 (D15S128, D15S122,
D15S97, GABRB3 155CA-2, and D15S156), pool 2
(D15S1506 and D15S10), and pool 3 (UBE3A OP2 and
UBE3A intron 1). Products were separated by use of
Performance Optimized Polymer-4 denaturing polymer
(Wenz et al., in press) and were sized with Genescan and
Genotyper, version 2.0, software (Applied Biosystems).
Data Analysis
Transmissions were determined by the extended
TDT program, version 1.6 (ftp://ftp.gene.ucl.ac.uk/pub/
packages/dcurtis). When one parent was missing, fam-
ilies were dropped for diallelic markers and for pairs in
which the child was homozygous or shared the same
genotype as the parent (Curtis and Sham 1995). At each
locus, alleles with parental counts less than five were
combined with other loci with counts less than five. If
this sum was less than five, these alleles were combined
with the least common allele until each allele (or group
of alleles) had a minimum count of five. Data were an-
alyzed by the multiallelic TDT (MTDT) (Spielman et al.
1993; Spielman and Ewens 1996). Since 20 loci, includ-
ing the 9 loci described in this report, have been analyzed
in this sample, Bonferroni correction leads to a corrected
significance threshold of .P ! .05/20  .0025
Results
Linkage disequilibrium was found between autistic
disorder and GABRB3 155CA-2 (MTDT 28.63, 10 df,
) (table 1). There was no evidence of parent-P  .0014
of-origin effects on GABRB3 155CA-2 transmission-
disequilibrium (table 2). None of the other markers in
the region showed statistically significant evidence of
linkage disequilibrium, by use of the MTDT (table 1).
Discussion
Linkage disequilibrium was found between GABRB3
155CA-2 and autistic disorder. GABRB3 155CA-2 has
been physically localized to the third intron, within 10-
kb of exons 1a, 1, 2, and 3 (Kirkness and Fraser 1993;
Glatt et al. 1994). D15S97 has been localized to the
fourth intron of GABRB3 (Glatt et al. 1997). Owing to
a 170-kb third intron, the GABRB3 155CA-2 and
D15S97 microsatellite markers are at least 150 kb apart
(Glatt et al. 1997). Linkage disequilibrium between loci
in a heterogeneous population would not be expected
to be strong for 150 kb, but linkage disequilibrium be-
tween loci within a gene may be larger than that between
other loci (Jorde et al. 1994; Jorde 1995). In addition,
linkage disequilibrium has extended over much larger
distances in single-gene disorders, such as cystic fibrosis.
Although the current finding is Bonferroni corrected for
the number of loci tested in this sample, the number of
loci that may be tested in autistic disorder and the ab-
sence of linkage disequilibrium with D15S97 provide
caution that the current finding may be a false positive,
owing to type I error. Genotyping of several markers in
GABRB3 and adjacentGABRA5 (Glatt et al. 1994) may
be useful in confirming and clarifying the presence and
extent of linkage disequilibrium between autistic dis-
order and markers in this region. A preliminary report
of weak linkage in an overlapping region of 15q11-13
(Pericak-Vance et al. 1997) provides some support for
the current finding, but a recent 10-cM genome screen
of affected-relative pairs did not find significant evidence
of linkage in this region (International Molecular Ge-
netic Study of Autism Consortium, 1998).
In addition to its location within 15q11-13, the
GABRB3 gene, which codes for the b3 subunit of the
g-aminobutyric acid (GABA)A receptor, is a candidate
gene for autistic disorder because of the role of the GA-
BAA receptor agonist benzodiazepine in the treatment of
seizures and anxiety disorders. Rates of anxiety disorder
previously had been found to be higher in the first-degree
relatives of probands with autistic disorder, compared
with the first-degree relatives of probands with Down
syndrome (Piven et al. 1991). In another study, first-
degree relatives of probands with autistic disorder had
a 10-fold elevation in social phobia, a specific anxiety
disorder, relative to first-degree relatives of probands
with tuberous sclerosis complex or a seizure disorder
without autistic disorder (Smalley et al. 1995). Testing
of linkage betweenGABRB3 and panic disorder, an anx-
iety disorder, was negative (Crowe et al. 1997), but social
phobia may be more related to autistic disorder suscep-
tibility than is panic disorder. No significant evidence for
linkage was found between GABRB3 markers and
schizophrenia (Byerley et al. 1995) or bipolar mood dis-
order (Coon et al. 1994).
Seizures and electroencephalographic abnormalities
have been reported in 125% of subjects with autistic
disorder (reviewed in Bailey et al. 1996). Testing of link-
age between the GABRB3/GABRA5/GABRG3 gene
cluster and idiopathic generalized epilepsy revealed ev-
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idence against linkage, by use of the entire family set
and subsets selected from either juvenile absence epilepsy
or childhood absence epilepsy. In 61 families of patients
with juvenile myoclonic epilepsy, a weakly positive LOD
score was found between a broad phenotype of idio-
pathic generalized epilepsy and this gene cluster (Sander
et al. 1997). However, haplotype–relative-risk testing of
GABRB3 155CA-2 was negative (Sander et al. 1997).
Another study, using the GABRB3 CA repeat 3′ of the
gene, found no association in a case-control study of
juvenile myoclonic epilepsy (Guipponi et al. 1997). Once
a sufficiently large number of families with probands
with autistic disorder and epilepsy are identified, testing
of linkage disequilibrium in this subgroup would be of
interest.
In the mature brain, GABA functions as an inhibitory
neurotransmitter, but changes, in the developing brain,
in the distribution of expression of GABAA receptor sub-
units indicate that it may function as a neurotrophic
factor affecting neural differentiation, growth, and cir-
cuit organization. The b3 subunit of the GABAA receptor
reaches peak expression at different times in different
brain regions, during pre- and postnatal murine devel-
opment. For example, peaks are reached prenatally in
the cerebral cortex, the hippocampus, and the thalamus
and postnatally in the cerebellar cortex (Laurie et al.
1992; Nadler et al. 1994). After peak expression, rapid
down-regulation occurs in the murine thalamus (Laurie
et al. 1992) and the inferior olive (Chang et al. 1995),
in which climbing fibers constitute a major functional
input to Purkinje neurons. Although, by adulthood, the
cerebral cortex and, to a lesser extent, the hippocampus
have lower levels of expression of the b3 subunit, ex-
pression in the cerebellum does not change during post-
natal maturation (Laurie et al. 1992; Nadler et al. 1994).
In the mature murine brain, the b3 subunit is most in-
tensely expressed in the cerebellum (Purkinje and granule
cells), the hippocampus, and the pyriform cortex (Wis-
den et al. 1992): all three of these regions consistently
have been reported to be anatomically abnormal in au-
tistic patients, in either quantitative magnetic-resonance
imaging or autopsy studies (reviewed in Bauman and
Kemper 1994; Courchesne 1997).
Mice with homozygous deletions of gabrb3 and a sur-
rounding region have been shown to have cleft palate
(95%), tremor, and jerky gait (Culiat et al. 1994). Mice
with a targeted disruption of gabrb3 have cleft palate
(57%) and occasional epilepsy, are hyperresponsive to
human contact and other sensory stimuli behavior, fail
to nurture offspring, often run in tight circles, and are
very hyperactive. Although gabrb3 knockout mice have
difficulty swimming, walking on grids, and remaining
on platforms and rotarods, they do not have jerky gait
(Homanics et al. 1997).
Although the cytogenetic evidence suggests a role of
imprinted-gene expression in 15q11-13 duplications
(Martinsson et al. 1996; Browne et al. 1997; Cook et
al. 1997b), the parent of origin did not have an effect
on preferential transmission of GABRB3 155CA-2 al-
leles. It is possible that a mutation in a regulatory region
disrupts the usual temporal and/or spatial expression
patterns of a gene or genes in the region. Moreover, it
is premature to speculate on mechanisms, until a func-
tional variant has been identified.
Until replicated and until functional variants are dem-
onstrated to have biological effects, these results must
be considered preliminary. Furthermore, apparent mei-
otic segregation distortion may contribute to the finding.
In addition to possible involvement of GABRB3, adja-
cent loci—including GABRA5 and expressed genes that
may not have been identified previously in the re-
gion—may be implicated by linkage disequilibrium.
Even if replicated, it is likely that a mutation in the region
would be one of several susceptibility loci in autistic
disorder and would pertain to a subset of families, owing
to the likely heterogeneity of this complex genetic
disorder.
Acknowledgments
We thank the families who participated in the study. Amy
Jersild, Cory Shulman, Elizabeth Moreno, Matthew Leventhal,
Jeremy Veenstra-Vanderweele, Pamela DiLavore, Susan Risi,
Jane Nofer, Marrea Winega, Saritha Matthew Vermeer, Senia
Pizzo, Zhi-Ying Yang, Mohammed Nawaz, and Shuya Yan
provided expert technical assistance. Valerie Lindgren, Soma
Das, and David Ledbetter provided chromosomal and DNA
diagnosis of cytogenetic disorders. This study was supported,
in part, by National Institutes of Mental Health (NIMH)
grants R01 MH52223 and 5 K02 MH01389 (to E.H.C.),
NIMH grant K05 MH01196 (to C.L.), National Institute of
Child Health and Human Development grant 1 P01 HD35482
(to E.H.C. and C.L.), and National Institute of Neurological
Disorders and Stroke grant 5 R01 NS 19855 (to E.C.); by the
Jean Young and Walden W. Shaw Foundation and the Harris
Foundation (support to B.L.L.); and by the Brain Research
Foundation (support to E.H.C.). The UBE3A intron 1 poly-
morphism was generously shared by Arthur Beaudet and Ping
Fang of the Baylor College of Medicine.
References
Albrecht U, Sutcliffe J, Cattanach B, Beechey C, Armstrong D,
Eichele G, Beaudet A (1997) Imprinted expression of the
murine Angelman syndrome gene, Ube3a, in hippocampal
and Purkinje neurons. Nat Genet 17:75–78
Bailey A, Le Couteur A, Gottesman I, Bolton P, Simonoff E,
Yuzda E, Rutter M (1995) Autism as a strongly genetic
disorder: evidence from a British twin study. Psychol Med
25:63–78
Bailey A, Philips W, Rutter M (1996) Towards an integration
1082 Am. J. Hum. Genet. 62:1077–1083, 1998
of clinical, genetic, neuropsychological, and neurobiological
perspectives. J Child Psychol Psychiatry 37:89–126
Baker P, Piven J, Schwartz S, Patil S (1994) Duplication of
chromosome 15q11-13 in two individuals with autistic dis-
order. J Autism Dev Disord 24:529–535
Bauman M, Kemper T (1994) Neuroanatomic observations of
the brain in autism In: Bauman ML, Kemper TL (eds) The
neurobiology of autism. Johns Hopkins University Press,
Baltimore, pp 119–145
Browne CE, Dennis NR, Maher E, Long FL, Nicholson JC,
Sillibourne J, Barber JCK (1997) Inherited interstitial du-
plications of proximal 15q: genotype-phenotype correla-
tions. Am J Hum Genet 61:1342–1352
Bundey S, Hardy C, Vickers S, Kilpatrick M, Corbett J (1994)
Duplication of the 15q11-13 region in a patient with autism,
epilepsy and ataxia. Dev Med Child Neurol 36:736–742
Byerley W, Bailey ME, Hicks AA, Riley BP, Darlison MG,
Holik J, Hoff M, et al (1995) Schizophrenia and GABAA
receptor subunit genes. Psychiatr Genet 5:23–29
Chang C, Luntz-Leybman V, Evans J, Rotter A, Frostholm A
(1995) Developmental changes in the expression of gamma-
aminobutyric acidA/benzodiazepine receptor subunit
mRNAs in the murine inferior olivary complex. J Comp
Neurol 356:615–628
Christian S, Bhatt N, Martin S, Sutcliffe J, Kubota T, Huang
B, Mutirangura A, et al (1998) Integrated YAC contig map
of the Prader-Willi/Angelman region on chromosome
15q11-q13 with average STS spacing of 35 kb. Genome Res
8:146–157
Comings DE, Comings BG, Muhleman D, Dietz G, Shahbah-
rami B, Tast D, Knell E, et al (1991) The dopamine D2
receptor locus as a modifying gene in neuropsychiatric dis-
orders. JAMA 266:1793–1800
Cook E, Courchesne R, Lord C, Cox N, Yan S, Lincoln A,
Haas R, et al (1997a) Evidence of linkage between the se-
rotonin transporter and autistic disorder. Mol Psychiatry 2:
247–250
Cook EH Jr, Lindgren V, Leventhal BL, Courchesne R, Lincoln
A, Shulman C, Lord C, et al (1997b) Autism or atypical
autism in maternally but not paternally derived proximal
15q duplication. Am J Hum Genet 60:928–934
Coon H, Hicks AA, Bailey ME, Hoff M, Holik J, Harvey RJ,
Johnson KJ, et al (1994) Analysis of GABAA receptor subunit
genes in multiplex pedigrees with manic depression. Psy-
chiatr Genet 4:185–191
Courchesne E (1997) Brainstem, cerebellar, and limbic neu-
roanatomical abnormalities in autism. Curr Opin Neurobiol
7:267–278
Crolla J, Harvey J, Sitch F, Dennis N (1995) Supernumerary
marker 15 chromosomes: a clinical, molecular and FISH
approach to diagnosis and prognosis. Hum Genet 95:
161–170
Crowe R, Wang Z, Noyes R Jr, Albrecht B, Darlison M, Bailey
M, Johnson K, et al (1997) Candidate gene study of eight
GABAA receptor subunits in panic disorder. Am J Psychiatry
154:1096–1100
Culiat CT, Stubbs LJ, Montgomery CS, Russell LB, Rinchik
EM (1994) Phenotypic consequences of deletion of the
gamma 3, alpha 5, or beta 3 subunit of the type A gamma-
aminobutyric acid receptor in mice. Proc Natl Acad Sci USA
91:2815–2818
Curtis D, Sham PC (1995) A note on the application of the
transmission disequilibrium test when a parent is missing.
Am J Hum Genet 56:811–812
DiLavore P, Lord C, Rutter M (1995) Pre-linguistic Autism
Diagnostic Observation Schedule (PL-ADOS). J Autism Dev
Disord 25:355–379
Flejter WL, Bennett-Baker PE, Ghaziuddin M, McDonald M,
Sheldon S, Gorski JL (1996) Cytogenetic and molecular
analysis of inv dup(15) chromosomes observed in two pa-
tients with autistic disorder and mental retardation. Am J
Med Genet 61:182–187
Folstein S, Rutter M (1977) Infantile autism: a genetic study
of 21 twin pairs. J Child Psychol Psychiatry 18:297–321
Gillberg C, Steffenburg S, Wahlstro¨m J, Gillberg I, Sjo¨stedt A,
Martinsson T, Liedgren S, et al (1991) Autism associated
with marker chromosome. J Am Acad Child Adolesc Psy-
chiatry 30:489–494
Glatt K, Glatt H, Lalande M (1997) Structure and organization
of GABRB3 and GABRA5. Genomics 41:63–69
Glatt K, Sinnett D, Lalande M (1994) The human gamma-
aminobutyric acid receptor subunit b3 and a5 gene cluster
in chromosome 15q11-q13 is rich in highly polymorphic
(CA)n repeats. Genomics 19:157–160
Guipponi M, Thomas P, Girard-Reydet C, Feingold J, Baldy-
Moulinier M, Malafosse A (1997) Lack of association be-
tween juvenile myoclonic epilepsy and GABRA5 and
GABRB3 genes. Am J Med Genet 74:150–153
He´rault J, Perrot A, Barthe´le´my C, Bu¨chler M, Cherpi C, Le-
boyer M, Sauvage D, et al (1993) Possible association of c-
Harvey-Ras-1 (HRAS-1) marker with autism. Psychiatry Res
46:261–267
Homanics GE, DeLorey TM, Firestone LL, Quinlan JJ, Hand-
forth A, Harrison NL, Krasowski MD, et al (1997) Mice
devoid of gamma-aminobutyrate type A receptor beta3
subunit have epilepsy, cleft palate, and hypersensitive be-
havior. Proc Natl Acad Sci USA 94:4143–4148
Hotopf M, Bolton P (1995) A case of autism associated with
partial tetrasomy 15. J Autism Dev Disord 25:41–49
International Molecular Genetic Study of Autism Consortium
(1998) A full genome screen for autism with evidence for
linkage to a region on chromosome 7q. Hum Mol Genet 7:
571–578
Jorde LB (1995) Linkage disequilibrium as a gene-mapping
tool. Am J Hum Genet 56:11–14
Jorde LB, Watkins WS, Carlson M, Groden J, Albertsen H,
Thliveris A, Leppert M (1994) Linkage disequilibrium pre-
dicts physical distance in the adenomatous polyposis coli
region. Am J Hum Genet 54:884–898
Kirkness E, Fraser C (1993) A strong promoter element is
located between alternative exons of a gene encoding the
human gamma-aminobutyric acid–type A receptor beta 3
subunit (GABRB3). J Biol Chem 268:4420–4428
Kishino T, Lalande M, Wagstaff J (1997) UBE3A/E6-AP mu-
tations cause Angelman syndrome. Nat Genet 15:70–73
Klauck SM, Poustka F, Benner A, Lesch K-P, Poustka A (1997)
Serotonin transporter (5-HTT) gene variants associated with
autism? Hum Mol Genet 6:2233–2238
Laurie D, Wisden W, Seeburg P (1992) The distribution of
thirteen GABAA receptor subunit mRNAs in the rat brain.
III. Embryonic and postnatal development. J Neurosci 12:
4151–4172
Cook et al.: Linkage Disequilibrium in Autism 1083
Leana-Cox J, Jenkins L, Palmer CG, Plattner R, Sheppard L,
Flejter WL, Zackowski J, et al (1994) Molecular cytogenetic
analysis of inv dup(15) chromosomes, using probes specific
for the Prader-Willi/Angelman syndrome region: clinical im-
plications. Am J Hum Genet 54:748–756
Lord C, Rutter M, Goode S, Heemsbergen J, Jordan H, Maw-
hood L, Schopler E (1989) Autism Diagnostic Observation
Schedule: a standardized observation of communicative and
social behavior. J Autism Dev Disord 19:185–212
Lord C, Rutter M, Le Couteur A (1994) Autism Diagnostic
Interview–Revised: a revised version of a diagnostic inter-
view for caregivers of individuals with possible pervasive
developmental disorders. J Autism Dev Disord 24:659–685
Martinsson T, Johannesson T, Vujic M, Sjostedt A, Steffenburg
S, Gillberg C, Wahlstrom J (1996) Maternal origin of inv
dup(15) chromosomes in infantile autism. Eur Child Adolesc
Psychiatry 5:185–192
Nadler LS, Guirguis ER, Siegel RE (1994) GABAA receptor
subunit polypeptides increase in parallel but exhibit distinct
distributions in the developing rat cerebellum. J Neurobiol
25:1533–1544
Pericak-Vance MA, Wolpert CM, Menold MM, Bass MP,
DeLong GR, Beaty LM, Zimmerman A, et al (1997) Linkage
evidence supports the involvement of chromosome 15 in
autistic disorder (AUT). Am J Hum Genet Suppl 61:A40
Pickles A, Bolton P, Macdonald H, Bailey A, Le Couteur A,
Sim C-H, Rutter M (1995) Latent-class analysis of recur-
rence risks for complex phenotypes with selection and mea-
surement error: a twin and family history study of autism.
Am J Hum Genet 57:717–726
Piven J, Chase GA, Landa R, Wzorek M, Gayle J, Cloud D,
Folstein S (1991) Psychiatric disorders in the parents of au-
tistic individuals. J Am Acad Child Adolesc Psychiatry 30:
471–478
Ritvo ER, Freeman BJ, Mason-Brothers A, Mo A, Ritvo A
(1985) Concordance for the syndrome of autism in 40 pairs
of afflicted twins. Am J Psychiatry 142:74–77
Robinson W, Binkert F, Gine´ R, Vazquez C, Mu¨ller W, Ro-
senkranz W, Schinzel A (1993) Clinical and molecular anal-
ysis of five inv dup(15) patients. Eur J Hum Genet 1:37–50
Robinson W, Lalande M (1995) Sex-specific meiotic recom-
bination in the Prader-Willi/Angelman syndrome imprinted
region. Hum Mol Genet 4:801–806
Sander T, Kretz R, Williamson M, Elmslie F, Rees M, Hild-
mann T, Bianchi A, et al (1997) Linkage analysis between
idiopathic generalized epilepsies and the GABA(A) receptor
alpha5, beta3 and gamma3 subunit gene cluster on chro-
mosome 15. Acta Neurol Scand 96:1–7
Schinzel AA, Brecevic L, Bernasconi F, Binkert F, Berthet F,
Wuilloud A, Robinson WP (1994) Intrachromosomal trip-
lication of 15q11-q13. J Med Genet 31:798–803
Smalley SL (1997) Genetic influences in childhood-onset psy-
chiatric disorders: autism and attention-deficit/hyperactivity
disorder. Am J Hum Genet 60:1276–1282
Smalley SL, McCracken J, Tanguay P (1995) Autism, affective
disorders, and social phobia. Am J Med Genet 60:19–26
Smalley SL, Tanguay PE, Smith M, Gutierrez G (1992) Autism
and tuberous sclerosis. J Autism Dev Disord 22:339–355
Sparrow S, Balla D, Cicchetti D (1984) Vineland scales of
adaptive behavior: survey form manual. American Guidance
Service, Circle Pines, MN
Spielman RS, Ewens WJ (1996) The TDT and other family-
based tests for linkage disequilibrium and association. Am
J Hum Genet 59:983–989
Spielman RS, McGinnis RE, Ewens WJ (1993) Transmission
test for linkage disequilibrium: the insulin gene region and
insulin-dependent diabetes mellitus (IDDM). Am J Hum Ge-
net 52:506–516
Steffenburg S, Gillberg C, Hellgren L, Andersson L, Gillberg
IC, Jakobsson G, Bohman M (1989) A twin study of autism
in Denmark, Finland, Iceland, Norway and Sweden. J Child
Psychol Psychiatry 30:405–416
Sutcliffe J, Jiang Y-H, Galjaard R-J, Matsuura T, Fang P, Ku-
bota T, Christian S, et al (1997) The E6-AP ubiquitin-protein
ligase (UBE3A) gene is localized within a narrowed Angel-
man syndrome critical region. Genome Res 7:368–377
Warren RP, Odell JD, Warren WL, Burger RA, Maciulis A,
Daniels WW, Torres AR (1996) Strong association of the
third hypervariable region of HLA-DR beta1 with autism.
J Neuroimmunol 67:97–102
Wenz W-H, Robertson JR, Menchen S, Oaks F, Demorest DM,
Scheibler D, Rosenblum BR, et al. High precision genotyping
by denaturing capillary electrophoresis. Genome Res (in
press)
Wisden W, Laurie D, Monyer M, Seeburg P (1992) The dis-
tribution of thirteen GABAA receptor subunit mRNAs in the
rat brain. I. Telencephalon, diencephalon, mesencephalon.
J Neurosci 12:1040–1062
